Fast movers • Alerts • Momentum
10% OFF with SAVE10
Charts • Watchlists • Multi-broker tools
Built for active traders
Biotech catalyst, news and analysis PDUFA tracker
Biotech catalyst, news and analysis PDUFA tracker
SNDL today is a hybrid animal: one of Canada’s largest private liquor and cannabis retailers, a vertically integrated cannabis operator and an investment platform deploying capital into the North American industry. The numbers are getting cleaner, the balance sheet is strong, but the equity story is still controversial.
Aurora Cannabis is a Canadian medical cannabis company undergoing a strategic transformation. In Q3 FY2026 (ended December 31, 2025), Aurora reported estimated $94.2M CAD in net revenue (+7% YoY), with record medical cannabis revenue of $76.2M CAD (+12% YoY). The company is pivoting aggressively toward high-margin global medical markets (especially Germany, Poland, Australia, UK), exiting lower-margin consumer segments in Canada, and divesting its plant propagation business.
Q4 2025 business update in focus: where Ocugen stands after another loss-making year, how the OCU400/410 platform is evolving, and what really matters for the next 18–24 months in gene therapy and anti-aging.
EN IT NASDAQ: KLTO Klotho Neurosciences Inc. Gene Therapy for Neurodegeneration + Strategic Minerals Division Market Cap: ~$39.6M | Price: $0.54 | YTD: -86.2% Chart: 1-year daily bars | Current Price: $0.54 | 52-week range: $0.11–$3.91 Data as of March…
Ondas’ Airobotics subsidiary has received a $20 million initial purchase order as prime contractor under a strategic national Autonomous Border Protection Program – the formal launch of a multi-year, multi-phase architecture built around thousands of AI-driven drones.
Deep dive after the March 4, 2026 Phase IIa update of Namodenoson in advanced pancreatic ductal adenocarcinoma (PDAC), with a full look at pipeline, balance sheet, governance, bull & bear case, and retail sentiment.
Ultra-microcap deep dive on Actelis Networks after a series of transportation, utility and carrier orders, reverse split and financing moves. Focus on the core technology, recent contracts, balance sheet stress and the asymmetry between operational progress and capital structure risk.
Asana Inc. (ASAN) – Work Management Platform & 2026 Growth Trajectory NYSE: ASAN · SaaS · Work Management Platform Asana Inc. (ASAN) – Scaling SaaS and 2026 Growth Trajectory SaaS deep-dive report – focus on product platform, financial performance, customer…
Headline today: Ocugen will host its Q4 and full-year 2025 conference call and live webcast today at 8:30 a.m. ET (14:30 CET), giving investors a first chance to hear management on cash, strategy and the OCU400 program, just days after the company announced completion of enrollment in the Phase 3 liMeliGhT trial for retinitis pigmentosa.
Mobix Labs, a tiny defense and connectivity component supplier, just caught a massive bid after announcing a new production order for its high-reliability filtering component inside the U.S. Navy Tomahawk cruise missile program. Behind the headline, the story is a mix of real programs (Tomahawk, M-1 Abrams, drone platform), aggressive M&A, heavy dilution and a very tight liquidity position.
From cannabis hype to beer-and-cannabis conglomerate: how Tilray is trying to turn a decade of dilution and volatility into a diversified, cash-generating platform built on craft beverages, medical distribution and North American optionality.
Canada-based cannabis company with operations spanning adult-use and medical cannabis in Canada and international markets, medical brands (including expanding insured-patient channels) and inhalation hardware via premium vaporizer brand Storz & Bickel.
A few days after the first wave of attacks, the war is no longer just a story of missiles over Tehran. It now stretches from southern Lebanon to the Strait of Hormuz, from Syrian and Iraqi corridors to the LNG hubs of Qatar and Saudi Arabia, with oil and gas prices repricing risk in real time.
L3Harris selects Intuitive Machines to provide satellite platforms for the Tracking Layer of the Space Development Agency’s Proliferated Warfighter Space Architecture (PWSA): a key step in LUNR’s transition from “lunar lander pure play” to integrated space-infrastructure and defense supplier, with rapidly changing fundamentals and a capital-intensive profile.
Red Cat has announced that Allen Control Systems (ACS), a specialist in autonomous precision weapon systems, is joining the Red Cat Futures Initiative – the company’s consortium aimed at accelerating advanced robotics and autonomy for modern warfare. The core of the deal is the integration of ACS’s Bullfrog system, an AI-driven robotic weapon station designed for counter-drone and precision engagement roles.
Revenue $54.3M in Q4 · $70.9M in FY 2025
First year as a revenue-generating company: gateway deliveries and initial U.S. government contracts pushed 2025 sales to $70.9M, with Q4 alone at $54.3M. The model is still loss-making: FY 2025 net loss attributable to common stockholders was about $342M, with Q4 loss around $74M and EPS of –$0.26 per share.
Time-critical logistics and clinical services for organ transplantation, now operating as a pure-play medical services platform after exiting passenger air mobility. Q4 2025 marks the first full quarter including Keystone’s perfusion business and a substantial reset of the 2026 growth trajectory.
Tonix Pharmaceuticals (TNXP) moves from Nasdaq Capital Market to the higher-tier Nasdaq Global Select Market and confirms a visible presence at TD Cowen and Barclays healthcare conferences in early March 2026.
Plug Power wants to be more than a meme hydrogen stock. In its filings and official presentations, the company describes itself as a provider of comprehensive hydrogen solutions that cover:
– Electrolyzers for green-hydrogen production,
– Production plants and liquefaction/purification infrastructure,
– Distribution and logistics (trailers, storage, on-site equipment), and
– End-use systems for material handling, stationary power and mobility.
The company prints a sharp revenue decline but a much narrower net loss, closes Ask Sage and CargoSeer, and walks into 2026 with over $460 million in cash and investments — at the price of massive dilution and a complex capital structure. Retail is back in the name, but the story is anything but low-risk.